Among cDCs, the cDC1 subset is the primary executor of cross‐presentation and is particularly adept at capturing and processing antigens derived from apoptotic or necrotic cells (e.g., tumor‐associated antigens), thereby efficiently priming CD8+ T‐cell responses [184, 185]. The gene discussed is CD8A; the disease is neoplasm.